Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

CORONARY ARTERY DISEASE IN LOW- TO INTERMEDIATE-RISK ASYMPTOMATIC PEOPLE WITH HIV: COMPARISON TO ASYMPTOMATIC COMMUNITY AND STABLE CHEST PAIN POPULATIONS WITHOUT KNOWN HIV

(2023) Julia Karady et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Incorporating estimands into clinical trial statistical analysis plans

(2022) Minhee Kang et al.   Clinical Trials

Cardiovascular disease risk in women living with HIV

(2022) Katherine Kentoffio et al.   Current Opinion in HIV and AIDS

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults

(2022) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Trends and Clinical Characteristics of HIV and Cerebrovascular Disease in Low- and Middle-Income Countries (LMICs) Between 1990 and 2021

(2022) George Ransley et al.   Current HIV/AIDS Reports

Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention

(2021) Udo Hoffmann et al.   JAMA Network Open

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

(2020) Theo Vos et al.   LANCET

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

(2019) Donna K. Arnett et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

(2019) Steven K. Grinspoon et al.   AMERICAN HEART JOURNAL

Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association

(2019) Matthew J. Feinstein et al.   CIRCULATION

Global Burden of Atherosclerotic Cardiovascular Disease in People Living with the Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis

(2018) Anoop S. V. Shah et al.   CIRCULATION

Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial

(2018) Mabel Toribio et al.   EBioMedicine

Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial

(2017) Judith A Aberg et al.   Lancet HIV

Types of Myocardial Infarction Among Human Immunodeficiency Virus–Infected Individuals in the United States

(2017) Heidi M. Crane et al.   JAMA Cardiology

A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research

(2016) Mirjam J. Curno et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Immune activation and cardiovascular disease in chronic HIV infection

(2016) Chris T. Longenecker et al.   Current Opinion in HIV and AIDS

Cardiovascular Complications of HIV in Endemic Countries

(2016) Matthew J. Feinstein et al.   Current Cardiology Reports

Effects of Antiretroviral Therapy on Immune Function and Arterial Inflammation in Treatment-Naive Patients With Human Immunodeficiency Virus Infection

(2016) Markella V. Zanni et al.   JAMA Cardiology

Rosuvastatin Reduces Vascular Inflammation and T-cell and Monocyte Activation in HIV-Infected Subjects on Antiretroviral Therapy

(2015) Nicholas T. Funderburg et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

(2015) Terry A. Jacobson et al.   Journal of Clinical Lipidology

Lack of Pharmacokinetic Interactions Between Pitavastatin and Efavirenz or Darunavir/Ritonavir

(2014) Carlos D. Malvestutto et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Effect of 24 Weeks of Statin Therapy on Systemic and Vascular Inflammation in HIV-Infected Subjects Receiving Antiretroviral Therapy

(2014) A. R. Eckard et al.   JOURNAL OF INFECTIOUS DISEASES

Risk of coronary heart disease in patients with HIV infection

(2014) Markella V. Zanni et al.   Nature Reviews Cardiology

HIV Infection, Vascular Disease, and Stroke

(2014) Felicia Chow   SEMINARS IN NEUROLOGY

Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men

(2013) Markella V. Zanni et al.   AIDS

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

(2013) David C. Goff et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

HIV Infection and the Risk of Acute Myocardial Infarction

(2013) Matthew S. Freiberg et al.   JAMA Internal Medicine

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein

(2009) Paul M Ridker et al.  

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE